REP8839

REP8839 Uses, Dosage, Side Effects, Food Interaction and all others data.

REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).

REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor with potent antibacterial activity against clinical isolates of Staphylococcus aureus, Streptococcus pyogenes, and other clinically important gram-positive bacteria but little activity against gram-negative bacteria.

Trade Name REP8839
Generic REP8839
Type
Protein binding

REP8839 is highly bound to human serum proteins.

Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
REP8839
REP8839

Uses

For the treatment of bacterial infections caused by susceptible microorganisms (Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), and Streptococcus pyogenes).

How REP8839 works

REP8839 exerts its antibacterial activity through specific inhibition of MetS, a novel target.

Innovators Monograph

You find simplified version here REP8839

*** Taking medicines without doctor's advice can cause long-term problems.
Share